Cetera Trust Company N.A Purchases New Shares in CVS Health Corporation $CVS

Cetera Trust Company N.A purchased a new position in shares of CVS Health Corporation (NYSE:CVS) in the second quarter, HoldingsChannel.com reports. The firm purchased 17,568 shares of the pharmacy operator’s stock, valued at approximately $1,817,000. CVS Health accounts for 0.9% of Cetera Trust Company N.A’s holdings, making the stock its 29th biggest holding.

A number of other institutional investors also recently bought and sold shares of CVS. Aberdeen Wealth Management LLC purchased a new position in shares of CVS Health during the second quarter worth about $104,000. Visionary Wealth Advisors purchased a new stake in CVS Health during the 2nd quarter valued at approximately $1,240,000. Cullen Capital Management LLC acquired a new stake in CVS Health during the 2nd quarter worth approximately $491,000. Algert Global LLC purchased a new position in shares of CVS Health in the 2nd quarter valued at approximately $897,000. Finally, Investor s Fiduciary Advisor Network LLC acquired a new position in shares of CVS Health in the second quarter valued at approximately $243,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CVS has been the subject of several analyst reports. DA Davidson increased their price target on CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. upped their price objective on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Truist Financial lifted their target price on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, Robert W. Baird set a $107.00 price target on shares of CVS Health in a research note on Thursday, August 6th. Twenty-two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Trading Up 1.1%

Shares of CVS opened at $94.06 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The stock has a market cap of $120.31 billion, a price-to-earnings ratio of 24.88, a price-to-earnings-growth ratio of 0.85 and a beta of 0.61. The firm has a 50 day simple moving average of $101.88 and a 200-day simple moving average of $89.08.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.